February 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1


Rolling All Ranks Non-federal Health Policy

Robert Wood Johnson Foundation
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health - Open Call for Proposals

To support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships. Of special interest is research examining the health impacts of programmatic or policy interventions that address factors outside the domain of health care services or public health practice.
Due Dates: Applications accepted on a rolling basis, there is no deadline for submission.  Applicants notified w/in 6-8 weeks of Letter of Intent.  Full proposals are due 2 months after invitation.
Amount & Project Period: No explicit range for allowable budget requests - 3  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Call for Proposals | Apply Online

R18 - Research Demonstration and Disseminations Projects

January 25 All Ranks Federal Safe Medication Use

Agency for Healthcare Research and Quality Advancing Patient Safety Implementation through Safe Medication Use Research

This FOA will fund investigative research demonstration projects that examine the effective implementation of processes, policies, and behaviors that support safe use of medication as well as its sustainment and dissemination.
Due Dates: Jan. 23 (OSR) Ι Jan. 25 (Sponsor)
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-421
R21 NCI

January 27 (LOI) All Ranks Federal Molecular & Cellular Analysis Technologies

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Exploratory research projects focused on early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. Emphasis is on supporting development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-010
R33 NCI

January 27 (LOI) All Ranks Federal Molecular/Cellular Analysis

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Research applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link:  RFA-CA-17-011
R21 NCI

January 27 (LOI) All Ranks Federal Technologies - Biospecimen Science

Innovative Technologies for Cancer-Relevant Biospecimen Science

Exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care, including new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-012
R33 NCI

January 27 (LOI) All Ranks Federal Biospecimen Science

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research

Exploratory research projects focused on further development and validation of emerging technologies that improve quality of samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. 
Due Dates: January 27 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Additional Due Dates: May 26; Sept. 26
Amount & Project Period: $300,000/yr. (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-013
R01 NIH

Revision applications to active NIH R01 awardees

               

January 30 (LOI) See Below Federal Biomarker Assay Validation

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants

Specific focus is on adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response to treatment, as well as markers for cancer control and prevention.  Research applications may support acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay.
Due Dates: Jan. 30 (Letter of Intent)
Feb. 24 (OSR) Ι Feb. 28 (Sponsor)
Addnl. Due Dates: July 11 & Oct. 27, 2017
Amount & Project Period: $150,000/yr. (Direct Costs) - Parent grant must be active when application is submitted. There must be a minimum 2 years of support remaining on parent award (not to include a no cost extension) at estimated time of award.
Eligibility: The PD(s)/PI(s) on the revision must be the PD(s)/PI(s) on the parent grant, but other PD(s)/PI(s) may be the leaders of the assay validation team.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-003


January 31 All Ranks Non-federal Pancreatic

The National Pancreas Foundation
Research Grants

Research must be in the field of pancreatic diseases. Studies intended to advance knowledge in the areas of pancreatic carcinoma, and all forms of pancreatitis would be the closest to the areas of interest of the NPF.
Due Dates: Jan. 26 (OSR) Ι Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview

January 31 All Ranks Non-federal Sarcoma

Sarcoma Foundation of America
Research Grants

This program provides grants to investigators interested in translational science sarcoma research The Foundation will only accept applications that focus on the following areas of research:
   Omic characterization of sarcomas and definition of novel targets
   Omic patterns of sensitivity and resistance to existing agents
   Systemic therapy combinations
   Immunotherapy
Due Dates: Jan. 27 (OSR) Ι Jan. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply for a Grant
FAQs
proposalCENTRAL (Submission Site)



January 31 Junior Faculty Non-federal Career Development

American Thyroid Association (ATA)
ATA Call for Research Grants

Funds available to support investigator initiated research projects in the area of thyroid function and disease.  Topics may include, but are not limited to, Clinical Disorders of Thyroid Function, Thyroid Autoimmunity, Thyroid Cancer, Thyroid Hormone Effect and Metabolism, Thyroid Imaging, Thyroid Nodules and Goiter.
Due Dates: Jan. 31 (Letter of Intent)
Invited Submissions:  May, 2017
Amount & Project Period: $50,000 (Direct Costs) - 2 years
Eligibility: Must be new investigators <6 years from completion of post-doctoral fellowship and not been PI on an NIH RO1 or equiv. grant (recipients of NIH R29, R21 and KO8 awards are eligible); Postdocs are eligible if their department provides written confirmation that at time of award that applicant will have a junior faculty position;
Must be ATA member or apply for complimentary membership.
Contact: Office of Sponsored Research (x6804)
Links: Call for Research Grants Proposals Ι ATA


January 31 (LOI) Faculty Non-federal Myelodysplastic Syndromes (MDS)

Edward P. Evans Foundation
Discovery Research Grants 2017

The focus for highly innovative and novel research awards will be on transformational basic, translational or aspects of clinical research directly applicable to the etiology, pathogenesis or treatment of MDS.
Due Dates: January 31, 2017 (Letter of Intent)
Invited Proposals:  Date is TBN - Early April
Amount & Project Period: Up to $200,000 - 1 year (Renewable)
Eligibility: Must be established independent investigators w/a tenure-track or tenured appointment at Asst. Professor level (or equiv.), or higher.
Contact: Office of Sponsored Research (x6804)
Links: General Funding Information Request for Letters of Intent

NEW
February 01 (LOI) All Ranks Federal PCOR

Patient Centered Outcomes Research Institute
Eugene Washington PCORI Engagement Awards: Knowledge, Training and Development, and Dissemination Awards

The program will award grants to projects encouraging active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise.
Due Dates: Feb. 01(Letter of Intent)
An LOI must be submitted before completion of a full proposal. PCORI convenes regularly to discuss submitted LOIs and will determine whether to deny or invite to submit a full proposal. Applicants will receive communication from PCORI no later than 40 days after LOI submission.
Amount & Project Period: $250,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Key Information


NEW
February 01 (LOI) Full Professors Non-Federal Research Support

American Cancer Society (ASC)
Research Professor Awards

Flexible funding for established investigators in mid-career who have made seminal contributions that have changed the direction of cancer research.  It is expected that these investigators will continue to provide leadership in their research area. An ACS Research Professor is required to be a spokesperson for the ACS and for cancer research.
Due Dates: Feb. 01 (Letter of Intent)
Invited Application:  Mar. 29 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: $400,000 - 5 years
Eligibility: Applicants will have attained rank of full professor or equiv. and must not have held this rank for more than 15 years.
Awardee will accept the role of speaking on behalf of the American Cancer Society and using the title as appropriate in professional appearances and publications.
Contact: Office of Sponsored Research (x6804)
RFA Link: proposalCENTRAL (contains RFP information and is submission site)


February 01 (LOI) Junior Faculty Non-federal Career Development

Leukemia Research Foundation
Hollis Brownstein New Investigator Research Program  

This program allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. Preference given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma.
Due Dates: Feb. 01 (Letter of Intent)
Invited Applications:  Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period:  $100,000 - 1 year
Eligibility: New Investigators are considered to be w/in 7 years of first independent position;
Applicants with an NIH KO8 or K23 are eligible;
See application information for additional information
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Application Instructions
U24 NCI

NEW
February 01 (LOI) All Ranks Federal Immunotherapy

Cancer Immune Monitoring and Analysis Centers (CIMACs)

The purpose is to solicit applications for multidisciplinary Cancer Immune Monitoring and Analysis Centers (CIMACs) that will serve as the main units of the Network for correlative studies in clinical trials involving immunotherapy.  The long term goal of the CIMACs-CIDC Network is to develop molecular signatures that define immune response categories to correlate with the clinical outcomes of immunotherapy in cancer.
Due Dates: Feb. 01 (Letter of Intent)
Applications: Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Max. $1.4M (Direct Costs) in any year - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-005
Companion RFA: RFA-CA-17-006 Cancer Immunologic Data Commons (CIDC) (U24)
U54 NCI

February 01 (LOI) All Ranks Federal Precision Medicine

PDX Development and Trial Centers (PDTCs)

Applications are sought for PDX (patient-derived xenografts) Development and Trial Centers (PDTCs) to serve as laboratory research units of the PDX Development and Trial Centers Research Network (PDXNet). The PDXNet coordinates collaborative, large-scale development and pre-clinical testing of targeted therapeutic agents in patient-derived models to advance the vision of cancer precision medicine.  The main goals for PDTCs include:
Development of new PDX models and methods for preclinical testing of single agents and drug combinations; and
Conducting studies of response of PDX models to novel therapeutic strategies using the newly established models as well as other existing well-characterized PDX models.
Due Dates: Feb. 01 (Letter of Intent)
Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Not to exceed $800,000/yr. (Direct Costs) - 5 years (req'd.)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-003
Companion RFA: RFA-CA-17-004, (U24 Resource-Related Research Projects - Cooperative Agreement) 
U54 NCI

February 01 (LOI) All Ranks Federal Drug Resistance/Sensitivity

Mechanisms of Cancer Drug Resistance and Sensitivity

The goal is to create a network of Drug Resistance and Sensitivity Centers (DRSCs) to develop innovative strategies to study mechanisms of tumor resistance or sensitivity to anticancer therapy.  Each DRSC should be based on 2-3 interrelated research projects. Applicants may propose collaborative arrangements (w/in 1 institution and/or with partnering institutions) to ensure all capabilities that might be necessary to fulfill the need for highly specialized multidisciplinary expertise.
Due Dates: Feb. 01 (Letter of Intent)
Mar. 01 (OSR) Ι Mar. 03 (Sponsor)
Amount & Project Period: Not to exceed $750,000/yr. (Direct Costs) 5 years (req'd.)
Eligibility: All Ranks - Note:  Given the potential for multi-disciplinary and multi-institutional teams, applicants are encouraged to take advantage of the multiple PDs/PIs option.  An individual may be designated as a PD/PI only on one DRSC application
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-009


February 05 All Ranks Federal Shared Decision Making

Agency for Healthcare Research and Quality (AHRQ)
Developing Measures of Shared Decision Making (R01)

The purpose is to invite applications to develop, test, and evaluate measures of Shared Decision Making that can be used to conduct research in clinical settings.
Due Dates: Feb. 02 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Not to exceed $1,500,000 (TOTAL) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-424
R01 NIH
February 05 All Ranks Federal See FOA

R01 Funding Opportunity Announcements with Standard Due Dates

Below is a short list of a few of the new/renewed Funding Opportunity Announcements (FOAs) where the National Cancer Institute is either the lead or is a participating institute.
Standard due dates apply.
Due Dates: Feb. 02 (OSR) Ι Feb. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link and Title: PA-13-354  Advancing the Science of Geriatric Palliative Care
 PA-17-018  Palliative Care Needs of Individuals with Rare
                     Advanced   Diseases and Their Family Caregivers
PA-17-041  Addressing the Etiology of Health Disparities and
                     Health Advantages among Immigrant Populations
PA-17-043  Addressing Health Disparities through Effective
                     Interventions among Immigrant Populations
PA-17-060  Oral Anticancer Agents: Utilization, Adherence, and
                     Health Care Delivery
U01 NCI

NEW
February 07 (LOI) All Ranks Federal Pancreatic

Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment

The purpose is to stimulate research in the area of PDAC microenvironment with the ultimate goal of understanding the interaction between tumors and the microenvironment. The plan is to design new immunotherapy and combination interventions that would accommodate and build on the distinct characteristics of this interaction.
Due Dates: Feb. 07 (Letter of Intent)
Applications:  Mar. 03 (OSR) Ι Mar. 07 (Sponsor)
Amount & Project Period: Limited to $350,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-015
Companion RFA: RFA-CA-17-016 Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24)
R01 NIH

February 07 All Ranks Federal Cancer and Behavior

Cancer-related Behavioral Research through Integrating Existing Data

To encourage applications that incorporate Integrative Data Analysis (IDA) methods to study behavioral risk factors for cancer, including tobacco use, sedentary behavior, poor weight management, and lack of medical adherence to screening and vaccine uptake.  Importantly, applicants should use existing data sources rather than collect new data.  Creating harmonized measures, developing culturally sensitive measures, replicating results and cross-study comparisons will be encouraged.
Due Dates: Feb. 05 (OSR) Ι Feb. 07 (Sponsor)
Additional Due Date:  June 07, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-256
Companion FOA: PAR-16-255 (R21)

NEW
February 08 (LOI) All Faculty Non-federal Bladder Cancer

Bladder Cancer Advocacy Network (BCAN)
2017 Bladder Cancer Research Innovation Award

Proposals will be accepted for creative ideas and innovative approaches that have direct application and relevance to bladder cancer. New ideas and innovative approaches may include, but are not limited to, those that utilize novel theoretical concepts, approaches or methodologies, instrumentation, or interventions. Proposals for innovative projects that will develop preliminary data necessary to prepare and submit a competitive research grant application to a major funding agency are encouraged.
Due Dates: Feb. 08 (Letter of Intent)
Invited Applications: May 01 (OSR) Ι May 03 (Sponsor)
Amount & Project Period: $300,000 - 2 years
Eligibility: Applicant must have a medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research;
Applicant must be an independent investigator;
Proof of permanent resident status or a valid work visa is required if the applicant is not an American or Canadian citizen.
Contact: Office of Sponsored Research (x6804)
Link: proposalCENTRAL (Guidelines and Submission Site)


NEW
February 12 Postdocs/Junior Faculty Non-federal Myelodysplastic Syndromes

MDS Foundation Young Investigator Grant

The purpose is to provide an investigator, aged 40 years or less, the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes.
Due Dates: Feb. 09 (OSR) Ι Feb. 12, 11:59pm EST (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: US or International applicant, 40 years old or less on the date of application submission
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP
K-Awards NCI

February 13 See FOA Federal Career Development

NCI  K-Awards Summary

 
NOTICE "All applications for K award funding must now have prior approval from REX.  Discuss your submission plans with your ACD prior to starting an application."
Due Dates: Feb. 09 (OSR) Ι Feb. 13 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Up to $100,000/year salary
$30,000 to 50,000/yr.  Research Development Costs, depending on award mechanism.
Duration of award is 3-5 years depending on mechanism.
Awards are not renewable.
Contact: Office of Sponsored Research (x6804)
For detailed information, including eligibility and funding on the K-mechanisms listed below, please see Cancer Training at NCI or the Funding Opportunity announcement listed with each mechanism.  

NCI K07 Award - Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (PAR-16-284) NOTE:  The last due date to submit a new application and to also be able to resubmit that application if it does not receive a fundable score will be February 13, 2017, and for any new/resubmission K07 applications the final dates will be October 12/November 13, 2017.

NCI K08 Award - Mentored Clinical Scientist Research Career Development Award (PA-16-191)

NCI K22 Award - The Transition Career Development Award (PAR-16-293)
                               The Transition Career Development Award to Promote Diversity (PAR-17-069)

NCI K23 Award - Mentored Patient-Oriented Research Career Development Award (PA-16-198)

NCI K99 Award - The Pathway to Independence Award – (PA-16-193)  
Admin. Supplements NIH
NCI is a participating Institute

NEW
February 13 See Below Federal Sex/Gender Influences

Administrative Supplement for Research on Sex/Gender Influences

 The purpose is to support research highlighting the impact of sex/gender influences and/or sex and gender factors in human health and illness, including basic, preclinical, clinical and behavioral studies.  Of special interest are studies relevant to understanding the significance of biological sex on cells and tissue explants; comparative studies of male and female tissues, organ systems and physiological systems; sex-based comparisons of pathophysiology, biomarkers, gene expression, clinical presentation and prevention and treatment of diseases.  Proposed research must address at least one objective from Goals 1 through 3 of the NIH Strategic Plan for Women's Health Research.
Due Dates: Feb. 09 (OSR) Ι Feb. 13 (Sponsor)
Amount & Project Period: Max. $65,000 (Direct Costs) - 1 year Must be w/in currently approved project period for existing parent grant and parent must have at least 18 months of active grant support remaining from the administrative supplement application due date.
Eligibility: Individual(s) must hold an active grant or cooperative agreement, and research proposed in the supplement must be accomplished within the competitive segment of active award
Contact: Office of Sponsored Research (x6804)
RFA Link: PA-17-078
U24 NIH
Common Fund Initiative
February 14 (LOI) All Ranks Federal The Druggable Genome

Data and Resource Generation Centers for Illuminating the Druggable Genome

The overarching goal of this FOA and its companion announcements is to generate a research consortium to facilitate the unveiling of the functions of selected understudied proteins in the Druggable Genome using experimental and informatics approaches.   This FOA calls for utilization of ensembles of scalable technology platforms to characterize functions of understudied non-olfactory G protein-coupled receptors (GPCRs), protein kinases, and ion channels at molecular and cellular levels in medium- to high-throughput fashion, rather than by a "one at a time" approach.
Due Dates: Feb. 14 (Letter of Intent)
Applications due:  Mar. 10 (OSR) Ι Mar. 14 (Sponsor)
Amount & Project Period: Max. $1.6M/yr. (Direct Costs) - 6 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-16-026
Companion RFAs: RFA-RM-16-024 U24 - Knowledge Management Center for Illuminating the Druggable Genome
RFA-RM-16-025 U24 - Resource Dissemination and Outreach Center for Illuminating the Druggable Genome
R03 NIH
Common Fund Initiative

NEW
February 14 All Ranks Federal Metabolomics

Novel Analytical Approaches for Metabolomics Data  

The purpose is to foster collaboration between computational scientists, metabolomics experts, and biomedical researchers in developing,  piloting, and/or validating novel bioinformatics approaches that address current analytical hurdles in metabolomics data.
Due Dates: Feb. 10 (OSR) Ι Feb. 14 (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-001

February 14 (LOI) All Ranks Federal PCOR

Patient Centered Outcomes Research Institute
Upcoming Opportunities - Cycle 1 2017

 
Due Dates: Feb. 14 (Letter of Intent)
Applications Due:  May 15 (OSR) Ι May 17 (Sponsor)
Additional Due Dates: Cycle 2 - 2017:  Jul. 25 (Letter of Intent)
                                        Cycle 3 - 2017:  Oct. 31 (Letter of Intent)
Amount & Project Period: See Specific Announcement
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Primary Link: Funding Opportunities
Addressing Disparities Funds & manages projects designed to reduce or eliminate health disparities, paying special attention to care delivery and outcomes. Disparities in health and healthcare quality and outcomes can be based on various factors, such as race, ethnicity, or socioeconomic status, which contribute to poor quality of care and overall health outcomes for specific populations.
  Assessment of Prevention, Diagnosis, and Treatment Options Comparative effectiveness research designed to provide information that would inform critical decisions that face patients and caregivers, clinicians, policy makers, and healthcare system leaders.
  Communication and Dissemination Research Focuses on comparing approaches to providing CER information, empowering people to ask for and use the information, and supporting shared decision making between patients and their providers
    Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes Pragmatic clinical trials (PCTs), large simple trials (LSTs), or large-scale observational studies that compare two or more alternatives for addressing prevention, diagnosis, treatment, or management of a disease or symptom; improving healthcare system-level approaches to managing care; or eliminating health or healthcare disparities.


NEW
February 15 All Faculty Ranks Non-federal Pancreatic

Pancreatic Cancer Action Network (PANCAN)
Early Detection Targeted Grant

This Request for Applications is to support ancillary research studies that identify promising blood biomarkers or imaging approaches that will eventually facilitate the use of specimens and/or participants in a cohort of new-onset diabetics and validate components of a protocol for the early detection of pancreatic ductal adenocarcinoma.
Due Dates: Feb. 13 (OSR) Ι Feb. 15 - Noon, EST (Sponsor)
Amount & Project Period: Up to $1,000,000 - 4 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply Now
Guidelines and Application Instructions
proposalCENTRAL


February 15 Postdocs Non-federal Career Development

Howard Hughes Medical Institute
Hanna H. Gray Fellows Program

This program seeks to increase diversity in the biomedical research community by recruitment and retention of individuals from groups underrepresented in the life sciences.
Due Dates: Feb. 13 (OSR) Ι Feb. 15, 3:00, pm ET (Sponsor)
Amount & Project Period: Fellowship Phase:        $160,000 - 2 years
Faculty Phase:              $270,000/yr. - 4 years (To transition to faculty phase, Fellows must obtain a faculty position in the tenure-track (or equiv.) at a U.S. (including Puerto Rico) research institution with a doctoral-level graduate program in their area of interest.)
Eligibility: The program is open to individuals who are from gender, racial, ethnic, and other groups under-represented in the life sciences, including those from disadvantaged backgrounds.
Applicants must have a PhD and/or MD(or equiv.) by start of the grant term.
Applicants can have no more than 12 months of postdoctoral research experience at application due date.
The program is open to applicants of any citizenship or nationality who have been accepted to join a laboratory as a postdoctoral fellow at a research institution located in the U.S. (including Puerto Rico).
Required to devote at least 75% of  total effort to research.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2017 Program Announcement


February 16 All Ranks Federal Heath & IT

Agency for Healthcare Research and Quality
Exploratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21)

The purpose of this FOA is to fund exploratory and developmental research that will contribute to the evidence base of how health IT improves health care quality.  This FOA supports the use of a wide variety of research designs in order to generate information regarding the design and development, implementation, use, or impact of health IT on quality. The 5 research areas of interest are: Design; Implementation; Use; Impact on Outcomes; and Measurement.
Due Dates: Feb. 14 (OSR) Ι Feb 16 (Sponsor)
Additional Due Dates:  Standard Due Dates
Amount & Project Period: $300,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Note:  Only 1 PD/PI may be designated.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-14-001
R21 NCI

February 16 All Ranks Federal Oral

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

The purpose is to encourage applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.
Due Dates: Feb. 14 (OSR) Ι Feb. 16 (Sponsor)                                        Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-061
Companion FOA: PA-17-060 (R01)


NEW
February 20 (LOI) Junior Faculty Non-federal Career Development

Lungevity Foundation
2017 Career Development Awards for Translational Research

Projects that will be funded in 2017 are expected to have a direct impact on early detection of lung cancer or on outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.
Due Dates: Feb. 20 (Letter of Intent) 9:00pm EST
Invited Applications:  May 03 (OSR) Ι May 05 (Sponsor)
Amount & Project Period: $300,000 - 3 years
Eligibility: Applicants must be w/in first 5 years of faculty appointment.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines | proposalCENTRAL (Submission Site)





NEW
February 20 Postdocs Non-federal Career Development

Society for Immunotherapy of Cancer (SITC)
2017 SITC Fellowship Awards

Supports development of young investigators in translational cancer immunotherapy to cultivate the next generation of cancer immunotherapy experts with a vested interest in furthering the clinical research of immunotherapy in lung cancer.
Due Dates: Feb. 16 (OSR) Ι Feb. 20  (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: Must be current SITC member;
Must hold an MD, PhD or combined MD/PhD degree;
Must currently hold position of postdoc., resident, research scientist or comparable position;
Must be w/in postdoc or postgraduate training, or <4 years from completing training;
Must commit 75% effort to research supported by fellowship
Contact: Office of Sponsored Research (x6804)
Link: Current Opportunities


NEW
February 22 - Noon, EST All Faculty Ranks Non-federal Pancreatic

Pancreatic Cancer Action Network (PANCAN)
Precision Medicine Targeted Grant

This Request for Applications is to solicit Precision Medicine Targeted Grant applications to provide funding for projects that can be incorporated directly into Precision Promise sub-studies at the end of the current funding period.
Due Dates: Feb. 20 (OSR) Ι Feb. 22 - Noon, EST (Sponsor)
Amount & Project Period: Up to $1,000,000 (Total) - 2 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply Now Ι Guidelines and Application Instructions
proposalCENTRAL
R01 NIH

NEW
February 23 New Investigators Federal Tobacco Regulatory Science

Tobacco Regulatory Science Small Grant Program for New Investigators

The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.  Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing.
Due Dates: Feb. 21 (OSR) Ι Feb. 23 (Sponsor) Final due date for this RFA
Amount & Project Period: Budgets limited to $75,000/yr. (Direct Costs) - 2 years
Eligibility: Only New Investigators are eligible.  FOA excludes individuals who have received the following from any NIH Institute or Center:
   Pathway to Independence Award-Research Phase (R00)
   Small Grant (R03) support in Tobacco Regulatory Science
   Exploratory/Developmental Grant (R21) in Tobacco Regulatory
   Science
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-15-004


NEW
February 27 All Ranks Moffitt See Below

Moffitt Innovative Studies Funding Opportunity - FORMA Therapeutics, Inc.

Moffitt Cancer Center invites Moffitt investigators (all ranks) to apply for funds for a grant within the broad areas of epigenetics, protein homeostasis, metabolism, immune oncology, and novel therapeutic targets.
Due Dates: Feb. 27 (OSR) Proposals must be submitted to OSR and OSR will forward by Mar. 01 to Alliance Management
Amount & Project Period: $100,000 (Direct Costs) - 12 months
Eligibility: All Ranks
Contact: Rae Reuille (x1548) or Alliance Management
Links: Guidelines  Ι  Application

NEW
February 28 All Faculty Ranks Non-federal Myelodysplastic Syndrome (MDS)

Aplastic Anemia and MDS International Foundation (AAMDISF)
Research Grants

Topic areas considered for funding include:
1.    Promoting understanding of the etiology and pathogenesis of aplastic anemia, MDS or PNH; 2.    Improving symptom management and the quality of life for aplastic anemia, MDS or PNH
       patients;
3.    Discovering new treatments for aplastic anemia, MDS or PNH;
4.    Understanding and preventing complications of bone marrow failure conditions (e.g., blood
       clotting/thrombosis in PNH, iron overload in MDS, etc.); and,
5.    Research regarding inherited bone marrow failure disorders, provided a strong case is also
       made for pertinence of the research to acquired disorders.
Due Dates: Feb 24 (OSR) Ι Feb. 28 (Sponsor)
Amount & Project Period: Up to $60,000 - 2 years
Eligibility: New & established Investigators - New Investigators are post-doctoral fellows, instructors and those who have been asst. professors for <5 years.  Established Investigators have been asst. professors for >5 years or are associate or full professors
Contact: Office of Sponsored Research (x6804)
Links: Fund Your Research Ι proposalCENTRAL (Submission Site)
R01 NCI

NEW
March 01 All Ranks Federal Cancer Imaging

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Additional 2017 Due Dates:  June 7th & October 3rd
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-093
Amin. Supplement NIH
NCI is a participating Institute

NEW
March 01 See Below Federal SGM Populations

Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations

This effort is intended to encourage investigation in an underrepresented, but growing, field of research. To increase collective understanding of the broad range of the health needs of SGM populations, the supplement will focus on areas of specific research interest, including, but not limited to: studies on increased disease risk; mental, behavioral and social health; approaches to personalized medicine; access to care; reproductive and sexual development; neurological and cognitive development; and resilience.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: Must not exceed $100,000 (total costs) – 1 year (Must be w/in currently approved project period of parent award.)
Eligibility: Individual(s) must hold an active grant or cooperative agreement, and research proposed in supplement must be accomplished w/in competitive segment of active award.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-098




NEW
March 01 Postdocs/Junior Faculty Non-federal Clinical Oncology/Fellowship

Dr. Charles A. Coltman, Jr., Fellowship Program

To pursue mentored clinical research initiatives.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Any oncology fellow in training OR
Junior faculty in the first 5 years of appointment at a member or affiliated SWOG Institution at application submission.
Contact: Office of Sponsored Research (x6804)
Link: Research & Funding



NEW
March 01 Postdocs Non-federal Career Development

Bonnie J Addario Lung Cancer Foundation (ALCF) and International Association for the Study of Lung Cancer (IASLC)
2017 ALCF-IASLC Joint Fellowship Award

The purpose is to support novel, innovative and translational research with potential of high clinical impact on the early detection of lung cancer.
Due Dates: Feb 27 (OSR) Ι Mar. 01, Receipt Date (Sponsor)
Amount & Project Period: $300,000 - 2 years
Eligibility: Applicants (MD/PhD/ MD, PhD) must be w/in 5 years of first faculty appointment as of June 5, 2015.
Applicants who have completed 2 years of fellowship/post-doctoral training and are on track for faculty appointments are eligible.
Documentation of an equal in-kind level of support (in the form of dedicated space, equipment, institutional overhead, core institutional resources, etc.) is required in a letter of support from the Cancer Center Director or Departmental Chairperson 
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


NEW
March 01 All Faculty Ranks Non-federal Leukemia

WES Leukemia Research Foundation
2017 Request for Proposals in Leukemia Research

Provides support for laboratory, translational, or clinical research related to acute leukemia.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor (Receipt Date))
Amount & Project Period: $50,000 - 1 year
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


NEW
March 01 Junior Faculty Non-federal Career Development

American Association for the Advancement of Science (AAAS)
Martin and Rose Wachtel Cancer Research Award

This award honors early-career investigators who have performed outstanding work in the field of cancer research.  As part of the application package, entrant will submit an essay describing his or her research project and explaining how it advances our understanding of cancer.  Award winner(s) are invited to deliver a public lecture on their research.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $25,000 cash award
Eligibility: Must have received Ph.D. or M.D. w/in last 10 years.
Research must have been performed during previous 10 years.
Applicant must have performed or personally directed work described in Essay.
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidelines

NEW
March 13 Junior Faculty Non-federal Career Development

The Prostate Cancer Foundation (PCF)
2017 PCF Young Investigator Awards

Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. "Small-step" or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to "bench to bedside" translational research proposals with the potential to deliver near term benefit to patients.
Due Dates: Mar. 09 (OSR) Ι Mar. 13, 3:00pm ET (Sponsor)
Amount & Project Period: $225,000/yr. - 3 years
Eligibility: Applicant sh/be w/in 6-years of completing a professional degree or clinical training, and must hold title of Postdoctoral Fellow, Instructor, Research Assoc., Asst. Professor or equiv;
Applicant should have received no more than $200,000 in current direct research funding from all sources including institutional funds;
Must be under direct supervision of a mentor
Contact: Office of Sponsored Research (x6804)
Links: RFA Ι Young Investigator Awards
Admin. Supplement NLM
NCI is a participating institute

NEW
March 15 See Below Federal Digital Research Data

NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects

These administrative supplements provide funds to active awards of participating Institutes and Centers in order to enhance the storage, organization, management and use of digital research data through the involvement of informationists, also known as in-context information specialists.
Due Dates: Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period: May not exceed $25,000/year (Direct Costs)
Project and budget periods must be w/in currently approved project period for the existing parent award and must be no more than 3 years.
Eligibility: Must hold an active grant or cooperative agreement, and research proposed in supplement must be accomplished w/in competitive segment of active award.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-090


NEW
March 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award

This program accepts project proposals for all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Due Dates: Mar 13 (OSR) Ι Mar. 15 (Receipt - (Sponsor))
(Application hard copy and USB flash drive required)
Amount & Project Period: $208,000 - Level 1 (PhD) - 4 years
$248,000 - Level 2 (US board cert. MD/PhD) - 4 years
Eligibility: This cycle is for those with degrees conferred between April 15, 2016 and March 15, 2017 and who joined sponsor's  lab on or after April 15, 2016.
Contact: Office of Sponsored Research (x6804)
Link: Award Overview


NEW
March 15 Junior Faculty Non-federal Career Development

The Sontag Foundation
The Distinguished Scientist Award (DSA)

This award will fund projects that show potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer.
Due Dates: Mar. 13 (OSR) Ι Mar. 15 (Noon - Sponsor(Receipt))
Amount & Project Period: $600,000 - 4 years
Eligibility: At time of application, applicants must hold first independent, tenure-track, full-time faculty appointment at assistant professor, independent researcher or equiv. level.
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidelines
U54 NCI

NEW
March 20 LOI All Faculty Federal Cancer Systems Biology

Research Centers for Cancer Systems Biology Consortium

This RFA invites applications for Research Centers that utilize systems biology approaches to build predictive models of cancer initiation, progression and metastasis. Cancer Systems Biology Consortium (CSBC) Research Centers will consist of interdisciplinary teams of scientists (e.g., engineers, chemists, computer scientists, mathematicians, physicists) and cancer researchers (e.g., cancer biologists, oncologists, pathologists) who collaborate to advance the understanding of cancer biology and oncology.
Due Dates: Mar. 20 (Letter of Intent)
Applications:  Apr. 18 (OSR) Ι Apr. 20 (Sponsor)
Note:  Pre-application webinar January 26 at 2:00pm
            (NOT-CA-17-011)
Amount & Project Period: May not exceed $1.5M/yr. (Direct Costs) - 5 years
Eligibility: All Faculty
Multi-PD/PI mechanism encouraged;
PD/PI (or contact PD/PI on proposals w/multiple PD(s)/PI(s)) must be a scientist w/formal training and/or expertise in cancer systems biology;
Leadership team must also include an additional PD(s)/PI(s) or other senior investigator w/appropriate primary expertise and substantial contributions in the field of cancer research.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-15-014
Companion FOA/RFA: PAR-16-131 (U01) Emerging Questions in Cancer Systems Biology
RFA-CA-15-015 (U24) Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org